相关实验视频
Updated: Jul 21, 2025

12:43
On-Chip Endothelial Inflammatory Phenotyping
Published on: July 21, 2012
11.0K
在健康和疾病中的内分泌蛋白-1
Katherine M R M Banecki1, Kim A Dora1
1Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.
International journal of molecular sciences
|July 29, 2023
概括
内甲素-1 (ET-1),一个强大的,影响生理学和病理学. 准ET-1为治疗心血管疾病,COVID-19和慢性疼痛提供了潜力,尽管治疗开发仍在进行中.
科学领域:
- 生物化学 生物化学
- 生理学 生理学 生理学
- 病理学 病理学 病理学
背景情况:
- 恩多林-1 (ET-1) 是一种强大的血管缩,具有显著的生理和病理作用.
- 最近的研究强调了ET-1对各种疾病的贡献,导致ET受体对手的发展.
- 尽管有已批准的肺动脉高血压治疗方法,但针对ET-1通路的更广泛的治疗成功仍然有限.
研究的目的:
- 总结有关ET-1合成,储存和释放的当前知识.
- 审查ET-1在诸如心血管疾病,COVID-19和慢性疼痛等疾病中的作用.
- 通过探索ET-1通路调节来确定潜在的新治疗途径.
主要方法:
- 对ET-1合成,储存和释放机制的文献综述.
- 对ET-1在各种病理状况中的参与进行分析.
- 检查针对ET-1通路的现有和潜在的治疗策略.
主要成果:
- ET-1在正常生理功能和疾病发病过程中起着至关重要的作用.
- ET-1与心血管疾病,COVID-19和慢性疼痛有关.
- 除了细胞培养之外,对ET-1合成和释放途径的研究是治疗进步所需的.
结论:
- 准ET-1通路对一系列疾病具有显著的治疗潜力.
- 开发专注于ET-1合成和释放的新策略可以克服当前对手的局限性.
- 进一步研究体外和体内模型对于将ET-1通路发现转化为有效的治疗方法至关重要.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
201
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
201
Hypertension II: Pathophysiology
15
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
15
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hormonal Regulation of Blood Pressure
2.7K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.7K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
692
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
692

